Kenneth Cundy

Kenneth Cundy

Director Técnico/Científico/I+D en ANEBULO PHARMACEUTICALS, INC. .

Fortuna: - $ al 31/07/2026

67 años
Health Technology
Consumer Services

Perfil

Kenneth C.
Cundy
currently works at Anebulo Pharmaceuticals, Inc., as Chief Scientific Officer from 2022.
Dr. Cundy also formerly worked at Gilead Sciences, Inc., as Senior Director-Biopharmaceutics from 1992 to 2000, CohBar, Inc., as Chief Scientific Officer from 2014 to 2022, and XenoPort, Inc., as Chief Scientific Officer from 2012 to 2014.
Dr. Cundy received his undergraduate degree from The University of Manchester and doctorate degree from the University of Kentucky.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
26/09/2025 0 ( -.--% ) - $ 31/07/2026

Cargos activos de Kenneth Cundy

EmpresasCargoInicio
ANEBULO PHARMACEUTICALS, INC. Director Técnico/Científico/I+D 20/05/2022

Antiguos cargos conocidos de Kenneth Cundy.

EmpresasCargoFin
COHBAR Director Técnico/Científico/I+D 31/03/2022
XENOPORT, INC. Corporate Officer/Principal 01/11/2014
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/01/2000
Ver el detalle de la experiencia de Kenneth Cundy.

Formación de Kenneth Cundy.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

53

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology